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Abstract
Introduction: The neurological manifestation of vitamin B12 deficiency can occur as a result of
peripheral nerve pathology or lateral and posterior column involvement, also known as “sub-acute
combined degeneration”. This case report demonstrates an unusual presentation of SCD with
normal B12 level.
Case presentation: A 39-year-old man was referred to the outpatient neurology clinic with a two
month history of distal upper extremities numbness and fine motor movement difficulties. Initial
vitamin B12 level was normal. A repeat MR imaging of the cervical and thoracic spine showed
extensive posterior cervical cord flame-shaped lesions. His repeat vitamin B12 level was 41 pg/ml
(normal; >200 ph/ml). He received monthly injections of vitamin B12. After six months his symptoms
were resolved and his repeat spinal MRI showed resolution of the previous lesions.
Conclusion: We recommend that every patient presenting with numbness and lesions on a spinal
MR imaging should have their vitamin B12 level checked.
Introduction
Vitamin B12 deficiency is a common disorder. Its
manifestations can range from asymptomatic to mega-
loblastic anemia. A wide spectrum of neurological
symptoms can also occur as a result of peripheral nerve
pathology or lateral and posterior column involvement,
also known as “sub-acute combined degeneration”.W e
present a patient with progressive neurological symptoms
including numbness and fine motor movement difficul-
ties. His borderline level of serum vitamin B12 initially led
to an extensive workup and relative delay in the diagnosis
of vitamin B12 deficiency as the cause of his symptoms.
This case report demonstrates an unusual presentation of
SCD with normal B12 level and emphasizes the impor-
tance of measuring methylmalonic acid and homocysteine
if vitamin B12 level is in the low normal limit.
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A 39-year-old African American man was referred to the
outpatient neurology clinic with a two month history of
distal upper extremities numbness and fine motor move-
ment difficulties. He denied any neck pain, lower
extremity symptoms, vision loss or any other neurological
deficit. His physical exam was normal, including a detailed
neurological exam. Laboratory evaluation six weeks prior
had revealed normal basic chemistry profile, HGB 11.9 g/
dl (MCV, and MCH values were not available at that time),
and B12 203 pg/ml (normal; >180 pg/ml). He also
underwent an EMG and nerve conduction study which
revealed mild bilateral carpal tunnel syndrome. Other
investigations conducted beforehand included MR ima-
ging of the cervical spine three weeks prior, which revealed
increased signal intensity within the core of the spinal cord
at the level of C 3-4 on T2 weighted sagittal images. Axial
images were not obtained at this level and contrast was not
used in this study. A repeat of his cervical and thoracic MR
imaging showed extensive posterior cervical cord flame-
shaped lesions on T2 weighted images (Figure 1, Figure 2,
Figure 3, Figure 4). Extensive laboratory evaluation was
unremarkable including: basic chemistry profile, erythro-
cyte sedimentation rate, TSH, angiotensin converting
enzyme, hemoglobin A1C, RPR, ANA, RF, serum protein
electrophoresis, iron studies, Lyme IgG antibodies and
heavy metals screen. His repeat Vitamin B12 level was
41 pg/ml, Methylmalonic acid 5.7 umol/l (normal;
<0.4 umol/l), Homocysteine >50 nmol/l (normal;
5-18 nmol/l), folate 12.7 ng/ml. Pernicious anemia was
suspected and investigation revealed positive intrinsic
factor antibodies and negative anti-parietal antibodies. He
received monthly injections of vitamin B12 replacement
therapy. After six months his symptoms were resolved and
his repeat spinal MRI showed resolution of the previous
lesions.
Discussion
The myelopathy in vitamin B12 deficiency, also known as
sub-acute combined degeneration (SCD), is caused by
demyelination of the posterior column and the lateral
tracts of the cervical and thoracic spine. Similar to our
patient, the most common initial complaint is paresthe-
sias and physical examination may be normal.
The MRI finding of patients with sub-acute combined
degeneration may reveal a regional T2 hyperintensity
mainly in the thoracic and cervical posterior column. The
differential diagnosis of an MRI with spinal posterior cord
lesion is vast and can include multiple sclerosis, infectious
myelitis, spinal infarction, and malignancies. Sub-acute
combined degeneration demonstrates contiguous involve-
ment in the posterior column of multiple segments of the
cord. However, in other etiologies of demyelinating
lesions, the spinal lesions are scattered and often do not
involve more than two vertebral bodies in length [1].
Furthermore, as in our patient, the improvement
of neurological symptoms and the resolution of the
MR imaging abnormalities following his vitamin B12
replacement supports this diagnosis.
It is important to distinguish B12 deficiency from other
causes of myelopathy as it is curable and early detection
is necessary for full clinical recovery. Checking serum B12
is used to confirm the diagnosis. However, when the level
Figure 1. Normal cervical spine T1 weighted MRI.
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levels of methylmalonic acid and homocysteine should
be used to coin the diagnosis. Spinal MR imaging with
features of SCD can also help detect early disease. Once
the diagnosis is confirmed, the treatment of a vitamin
B12 injection should be started as early as possible to
avoid irreversible neurological damage.
Our patient presented with unexplained numbness
and fine motor movement difficulties. His evaluation
was initially challenging because of the normal level
of vitamin B12. Multiple investigations and delayed
diagnosis might have been prevented if his metabolite
was measured first. Three weeks later, his spinal
MRI suggested the diagnosis of myelopathy and
the diagnosis of vitamin B12 deficiency was confir-
med by repeating the serum vitamin B12 level and
checking the levels of methylmalonic acid and
homocysteine.
Conclusion
We recommend that vitamin B12 level should be
checked in every patient presenting with numbness
and particularly in those with unexplained lesions on
a spinal MR imaging. Furthermore, methylmalonic
acid and homocysteine should also be measured if
vitamin B12 level is in the low normal limit.
MR imaging may be a useful addition to the clinical
assessment and in monitoring the efficacy of treatment
of vitamin B12 deficiency.
Abbreviations
EGD, esophagogastroduodenoscopy; EMG, electromyo-
graphy; MRI, magnetic resonance imaging; SCD, sub-acute
combined degeneration.
Figure 2. Flamed-shaped area of increased signal intensity
within the posterior column of the cervical spine on the
sagittal T2 weighted MRI.
Figure 3. Flamed-shaped area of increased signal intensity
within the posterior column of the cervical and thoracic spine
on the sagittal T2 weighted MRI.
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Figure 4. Increased signal intensity within the posterior column of the cervical spine on the axial T2 weighted MRI.
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